Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Journal of the American Chemical Society
|
January 18, 2020
Structure-Guided Improvement of a Dual HPIV3/RSV Fusion Inhibitor
Victor K Outlaw, Jennifer T Lemke, Yun Zhu, et al.
Journal of the American Chemical Society
|
July 4, 2019
Dual Inhibition of Human Parainfluenza Type 3 and Respiratory Syncytial Virus Infectivity with a Single Agent
Victor K Outlaw, Samantha Bottom-Tanzer, Dale F Kreitler, et al.
Research Square
|
July 29, 2024
Structural Characterization of Disulfide-Linked p53-Derived Peptide Dimers
Magdalena C DiGiorno, Nisansala Vithanage, Clara G Victorio, et al.
ACS Chemical Biology
|
July 7, 2025
SARS-CoV-2 Omicron Variant Spike Glycoprotein Mutation Q954H Enhances Fusion Core Stability
Nisansala Vithanage, Rifat Hasan Apurba, Hamza Enesi Ozomarisi, et al.
Journal of the American Chemical Society
|
May 25, 2022
Trimer-to-Monomer Disruption Mechanism for a Potent, Protease-Resistant Antagonist of Tumor Necrosis Factor-α Signaling
Jiani Niu, Annika J Cederstrand, Geoffrey A Eddinger, et al.
Journal of the American Chemical Society
|
April 7, 2021
Engineering Protease-Resistant Peptides to Inhibit Human Parainfluenza Viral Respiratory Infection
Victor K Outlaw, Ross W Cheloha, Eric M Jurgens, et al.
Journal of Virology
|
February 4, 2025
Enhancing the solubility of SARS-CoV-2 inhibitors to increase future prospects for clinical development
Ariel J Kuhn, Victor K Outlaw, Tara C Marcink, et al.
Mbio
|
October 21, 2020
Inhibition of Coronavirus Entry <i>In Vitro</i> and <i>Ex Vivo</i> by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain
Victor K Outlaw, Francesca T Bovier, Megan C Mears, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Journal of the American Chemical Society
|
January 18, 2020
Structure-Guided Improvement of a Dual HPIV3/RSV Fusion Inhibitor
Victor K Outlaw, Jennifer T Lemke, Yun Zhu, et al.
Journal of the American Chemical Society
|
July 4, 2019
Dual Inhibition of Human Parainfluenza Type 3 and Respiratory Syncytial Virus Infectivity with a Single Agent
Victor K Outlaw, Samantha Bottom-Tanzer, Dale F Kreitler, et al.
Research Square
|
July 29, 2024
Structural Characterization of Disulfide-Linked p53-Derived Peptide Dimers
Magdalena C DiGiorno, Nisansala Vithanage, Clara G Victorio, et al.
ACS Chemical Biology
|
July 7, 2025
SARS-CoV-2 Omicron Variant Spike Glycoprotein Mutation Q954H Enhances Fusion Core Stability
Nisansala Vithanage, Rifat Hasan Apurba, Hamza Enesi Ozomarisi, et al.
Journal of the American Chemical Society
|
May 25, 2022
Trimer-to-Monomer Disruption Mechanism for a Potent, Protease-Resistant Antagonist of Tumor Necrosis Factor-α Signaling
Jiani Niu, Annika J Cederstrand, Geoffrey A Eddinger, et al.
Journal of the American Chemical Society
|
April 7, 2021
Engineering Protease-Resistant Peptides to Inhibit Human Parainfluenza Viral Respiratory Infection
Victor K Outlaw, Ross W Cheloha, Eric M Jurgens, et al.
Journal of Virology
|
February 4, 2025
Enhancing the solubility of SARS-CoV-2 inhibitors to increase future prospects for clinical development
Ariel J Kuhn, Victor K Outlaw, Tara C Marcink, et al.
Mbio
|
October 21, 2020
Inhibition of Coronavirus Entry <i>In Vitro</i> and <i>Ex Vivo</i> by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain
Victor K Outlaw, Francesca T Bovier, Megan C Mears, et al.
Page
of 2